Unique “delta lock” structure of telmisartan is involved in its strongest binding affinity to angiotensin II type 1 receptor
Kazuki Ohno(Astellas Pharma (Japan)), Sho‐ichi Yamagishi(SHOWA Medical University), Shoji Takakura(Astellas Pharma (Japan)), Ryuichi Morishita(The University of Osaka), Y. Amano(Astellas Pharma (Japan)), Issei Komuro(University of Tokyo Hospital), Masaya Orita(Astellas Pharma (Japan)), Shokei Kim‐Mitsuyama(Kumamoto University), Yutaka Mori(Jikei University School of Medicine), Makoto Takeuchi(Astellas Pharma (Japan)), Hitoshi Sakashita(Astellas Pharma (Japan)), Keiji Miyata(Astellas Pharma (Japan)), Tatsuya Niimi(Astellas Pharma (Japan)), Masatsugu Horiuchi(Ehime University), Jitsuo Higaki(Saiseikai Matsuyama Hospital), Hirotoshi Kakuta(Astellas Pharma (Japan))
Cited by 37
Related Papers
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Adult Cardiac Sca-1-positive Cells Differentiate into Beating Cardiomyocytes
|Journal of Biological Chemistry|2004|636